Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Establishment Labs HoldingsFRA:3E0 +0.20%72 Days Payable is 219.44 as of Mar. 2026, which is 51% above its 10-year median of 145.35. GuruFocus rates FRA:3E0 with a GF Score™ of 72/100 and a GF Value™ of €53.91 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 794 Medical Devices & Instruments companies, Establishment Labs Holdings ranks better than 86.78% on this metric.
The historical rank and industry rank for Establishment Labs Holdings's Days Payable or its related term are showing as below:
FRA:3E0'
s Days Payable Range Over the Past 10 Years
Min: 87.32 Med: 145.35 Max: 279.03
Current: 239.61
During the past 10 years, Establishment Labs Holdings's highest Days Payable was 279.03. The lowest was 87.32. And the median was 145.35.
FRA:3E0's Days Payable is ranked better than 86.78% of 794
companies
in the Medical Devices & Instruments industry
Industry Median: 67.97
vs FRA:3E0: 239.61
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:3E0 vs TMDX, AXGN, ITGR: Days Payable Comparison
For the Medical Devices subindustry, Establishment Labs Holdings's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Establishment Labs Holdings Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Establishment Labs Holdings's Days Payable distribution charts can be found below:
* The bar in red indicates where Establishment Labs Holdings's Days Payable falls into.
Establishment Labs Holdings Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Establishment Labs Holdings (FRA:3E0) has a Days Payable of 219.44 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Establishment Labs Holdings and its competitors. This is 51% above median its historical median of 145.35. Over the past decade, Establishment Labs Holdings' Days Payable has ranged from 87.32 to 279.03. According to the industry distribution chart, Establishment Labs Holdings ranks #105 out of 794 companies in the Medical Devices & Instruments industry, placing it in the top 13.2%.
Is Establishment Labs Holdings' Days Payable too high?
Establishment Labs Holdings' current Days Payable of 219.44 is 51% above median its 10-year median of 145.35. Over the past 10 years, this metric has ranged from a low of 87.32 to a high of 279.03. The Medical Devices & Instruments industry median Days Payable is 67.97. Establishment Labs Holdings' value of 219.44 is 222.8% above this industry median. Based on the distribution chart, Establishment Labs Holdings ranks #105 out of 794 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Establishment Labs Holdings has a GF Score™ of 72/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Establishment Labs Holdings' Days Payable compare to TMDX and AXGN?
According to the Medical Devices & Instruments industry distribution chart, Establishment Labs Holdings ranks #105 out of 794 companies for Days Payable. This places Establishment Labs Holdings in the top 13% of its industry — outperforming the majority of peers. The industry median Days Payable is 67.97. Establishment Labs Holdings' value of 219.44 is 222.8% above this benchmark. Historically, Establishment Labs Holdings' own Days Payable has ranged from 87.32 to 279.03 over the past decade. While the company's 10-year median is 145.35 vs. the industry median of 67.97, Establishment Labs Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.97, based on 794 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Establishment Labs Holdings's current Days Payable of 219.44 is 222.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Establishment Labs Holdings and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Establishment Labs Holdings's current Days Payable is 219.44, which is 51% above median its own 10-year median of 145.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Establishment Labs Holdings stock overvalued right now?
Based on GuruFocus' analysis, Establishment Labs Holdings (FRA:3E0) is currently considered Significantly Overvalued. The stock's GF Value™ is €53.91, compared to a current price of €80.62 — trading 49.5% above its estimated fair value. The current Days Payable is 219.44, which is 51% above median its 10-year median of 145.35 and 222.8% above the Medical Devices & Instruments industry median of 67.97. Establishment Labs Holdings' overall GF Score™ is 72/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Establishment Labs Holdings (FRA:3E0), the current Days Payable is 219.44 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Establishment Labs Holdings (FRA:3E0) Overvalued in 2026?
Based on GuruFocus' analysis, Establishment Labs Holdings stock appears to be overvalued.
The current stock price of €80.62 is trading 49.5% above its estimated GF Value™ of €53.91.
GuruFocus considers Establishment Labs Holdings to be Significantly Overvalued.
Key valuation signals for FRA:3E0:
Days Payable: 219.44 (51% above median its 10-year median of 145.35)
GF Value™: €53.91 vs. price of €80.62 (49.5% above fair value)
Industry Position: 222.8% above the Medical Devices & Instruments median (#105 of 794)
No single metric tells the full story. See the FRA:3E0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.
72GF Score
Get the complete analysis for FRA:3E0
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:3E0 has been successfully added to your 
